221 related articles for article (PubMed ID: 22249422)
1. Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.
Lee NY; Wu JJ; Lin SH; Ko WC; Tsai LH; Yan JJ
Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1941-50. PubMed ID: 22249422
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital.
Wu JJ; Wang LR; Liu YF; Chen HM; Yan JJ
Microb Drug Resist; 2011 Jun; 17(2):259-66. PubMed ID: 21352075
[TBL] [Abstract][Full Text] [Related]
4. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
Antimicrob Agents Chemother; 2012 Jun; 56(6):2888-93. PubMed ID: 22430969
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
[TBL] [Abstract][Full Text] [Related]
7. Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
Leavitt A; Chmelnitsky I; Colodner R; Ofek I; Carmeli Y; Navon-Venezia S
J Clin Microbiol; 2009 Apr; 47(4):969-74. PubMed ID: 19213695
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
9. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
[TBL] [Abstract][Full Text] [Related]
10. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
11. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.
Endimiani A; Perez F; Bajaksouzian S; Windau AR; Good CE; Choudhary Y; Hujer AM; Bethel CR; Bonomo RA; Jacobs MR
J Clin Microbiol; 2010 Dec; 48(12):4417-25. PubMed ID: 20881179
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
[TBL] [Abstract][Full Text] [Related]
14. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
Gröbner S; Linke D; Schütz W; Fladerer C; Madlung J; Autenrieth IB; Witte W; Pfeifer Y
J Med Microbiol; 2009 Jul; 58(Pt 7):912-922. PubMed ID: 19502377
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.
Matsumura Y; Tanaka M; Yamamoto M; Nagao M; Machida K; Ito Y; Takakura S; Ogawa K; Yoshizawa A; Fujimoto Y; Okamoto S; Uemoto S; Ichiyama S
Int J Antimicrob Agents; 2015 Jan; 45(1):33-40. PubMed ID: 25455850
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G
Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases?
Yan JJ; Lee NY; Chen HM; Wang MC; Ko WC; Tsai LH; Wu JJ
Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):345-52. PubMed ID: 23001510
[TBL] [Abstract][Full Text] [Related]
19. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.
Chiu SK; Wu TL; Chuang YC; Lin JC; Fung CP; Lu PL; Wang JT; Wang LS; Siu LK; Yeh KM
PLoS One; 2013; 8(7):e69428. PubMed ID: 23894478
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Cai JC; Zhou HW; Zhang R; Chen GX
Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
